Navigation Links
Nutrigenomics -- developing personalized diets for disease prevention
Date:12/29/2008

New Rochelle, NY, December 29, 2008The emerging field of nutrigenomics, which aims to identify the genetic factors that influence the body's response to diet and studies how the bioactive constituents of food affect gene expression, is explored in a series of provocative, interdisciplinary reports and analyses in the December 2008 Special Issue (Volume 12, number 4) of OMICS: A Journal of Integrative Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The issue is available free online at www.liebertpub.com/omi

This compendium of papers describing the innovative new area of study encompassed by nutrigenomics research is Part 1 of a two-part series. Part 2 will be published in Spring 2009.

Nutrigenomic's bidirectional approach to investigating how the genetic traits of an individual or population interact with their diet offers many possibilities for targeted clinical interventions and preventive medicine. These may include modifying either diet or the biochemical response to food exposure to prevent disease in individuals shown to be susceptible to the consequences of unfavorable dietary/genomic interactions. In the future, nutrigenomics may potentially help guide the development of customized diets based on an individual's genetic make-up.

"In contrast to previous applications of genomics technologies where the goal is to distinguish existing disease from absence of disease, nutrigenomics aims to discern nuanced differences in predisease states such that personalized dietary interventions can be designed to prevent or modify future disease susceptibility," write Guest Editors Batrice Godard, PhD, and Vural Ozdemir, MD, PhD, from the Department of Social and Preventive Medicine, University of Montreal, Qubec, Canada.

"Nutrigenomics opens new and amazing frontiers in 21st century biomedical
'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Page: 1 2

Related biology news :

1. New gene variants present opportunities in nutrigenomics
2. Pigs and dogs can bridge gap between mice and humans in developing new therapies
3. Scientists developing food allergy treatment
4. Carnegie Mellon developing automated systems to enable precision farming of apples, oranges
5. Space researchers developing tool to help disoriented pilots
6. Repair in the developing heart
7. HPV DNA test identifies cervical pre-cancerous disease in developing countries with 90% success rate
8. ASM and FIND to partner on strengthening infectious disease diagnosis in developing nations
9. Fertility treatment in developing countries; a cycle of IVF for less than $200
10. New treatment approach promising for lymphoma patients in the developing world
11. Biotechnology key to developing sustainable industries says international panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... Minn. , June 23, 2015   ... company that supports the entire spectrum of clinical ... iMedNet ™ , the company,s intuitive, ... been awarded a Silver 2015 Stevie® Award by ... Health Products & Services Website category.  The American ...
(Date:6/18/2015)... , June 18, 2015 This report analyzes ... by the following Product Segments, which includes Immunoassay Analyzers ... Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. ... Canada , Japan ... , Latin America , and ...
(Date:6/17/2015)... JOSE, Calif. , June 17, 2015 /PRNewswire/ ... in human interface solutions, today announced that Xiaomi, ... adopted the Synaptics ® ClearPad ® ... of display driver integrated circuits (DDICs) for its ... Pro. By leveraging ClearPad for full in-cell display ...
Breaking Biology News(10 mins):MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... randomized, placebo-controlled U.S. clinical trial to assess the use ... a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated ... on phase 1 results published in the September issue ... "The use of adult stem cells, derived from the ...
... Wash. Washington State University researchers have discovered the mechanism by ... state. The finding clears the way for a suite of ... brain injuries. "We know that brain activity is linked ... WSU neuroscientist and lead author of a paper in the ...
... (September 14, 2010) -- Because one of the main ... producing good isolated single crystals, improved crystallization techniques would ... pharmaceutical research. Research reported in The ... (FCS) to investigate the processes at the surface of ...
Cached Biology News:First US trial of bone-marrow stem cells for heart attack patients proves safe 2WSU researchers discover key mechanism behind sleep 2How do your crystals grow? 2
(Date:7/1/2015)... 2015  Axovant Sciences Ltd. (NYSE:  AXON), a ... of dementia, today announced that the company will ... 5:45 p.m. EDT following its presentation of RVT-101 ... 2015 (AAIC). The event will ... Lawrence Friedhoff , Chief Development Officer, will ...
(Date:7/1/2015)... PHILADELPHIA , July 1, 2015 ... technology will ... s evidence-based clinical s olutions suite ... scientific, technical and medical information products and services, announced today ... -based clinical decision support (CDS) technology company. InferMed,s ...
(Date:7/1/2015)... NEW YORK , July 1, 2015 /PRNewswire/ ... G ), a global leader in designing, ... the Aecus Innovation Award in recognition of their ... operational efficiencies in UCB,s global business services (GBS) ... acknowledge service providers and clients that work together ...
(Date:6/30/2015)... - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that ... approved the resolutions relating to: (i) a private ... at a price of $2.67 per unit (the ... one common share and 0.075358 common share purchase ... and (ii) the amendment to Resverlogix,s articles to ...
Breaking Biology Technology:Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3
... Nov. 30 Binex,(KOSDAQ: 053030) and MaxCyte, Inc. ... to evaluate MaxCyte,s GMP-compliant cell,loading technology for use ... completion of the research studies,the agreement provides Binex ... commercial use in Korea. Financial terms were not ...
... Nov. 30 ABR-Affinity,BioReagents, a leading global antibody manufacturer, ... for Cell Biology,s,47th Annual Meeting in Washington D.C., December ... one of the most significant of the year in ... privileged to participate in,this exciting area of research," said ...
... Kinetics Study Data on ... Monday December 3, 2007, VANCOUVER ... MGIFF), a clinical-stage developer of drugs for infectious,diseases, will host a ... ET (8:00 a.m. PT) to discuss financial results for the,second fiscal ...
Cached Biology Technology:Binex and MaxCyte Collaborate on Cancer Immunotherapy Research 2ABR-Affinity BioReagents to Exhibit at ASCB in Washington D.C., December 1 - 5, 2007 2MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification 2